Showing results (51-60 of 201) with videos related to

Sort By:
Pageof 21
Journal of Gastrointestinal Oncology|March 14, 2022
Integrated omics analysis: the relationship between significantly increased <i>Klebsiella</i> post-hepatectomy and decreased hub-metabolite 3-methyl-2-oxobutanoic acid is associated with induced liver failureYu-Chong Peng, Xin-Hua Zhao, Chuan-Fa Zeng, et al.
Pathology, Research and Practice|November 5, 2013
Changes in ER, PR and HER2 receptors status after neoadjuvant chemotherapy in breast cancerYu-Feng Yang, Ying-Yang Liao, Le-Qun Li, et al.
Expert Review of Gastroenterology & Hepatology|June 20, 2020
Perioperative antiviral therapy improves the prognosis of HBV DNA-negative patients with HBV-related hepatocellular carcinomaChuan Li, Zhi-Cheng Li, Liang Ma, et al.
Oncotargets and Therapy|July 9, 2016
The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombusTao Bai, Jie Chen, Zhi-Bo Xie, et al.
Oncotarget|December 2, 2017
Surgical resection for hepatocellular carcinoma with portal vein tumor thrombus in the Asia-Pacific region beyond the Barcelona Clinic Liver Cancer treatment algorithms: a review and updateJia-Zhou Ye, Yan-Yan Wang, Tao Bai, et al.
BMC Surgery|February 15, 2017
Hepatectomy for liver metastases from gastric cancer: a systematic reviewYing-Yang Liao, Ning-Fu Peng, Di Long, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 21, 2014
Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic reviewZhi-Bo Xie, Liang Ma, Xiao-Bo Wang, et al.
World Journal of Gastroenterology|December 11, 2014
Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombusJia-Zhou Ye, Yong-Quan Zhang, Hai-Hong Ye, et al.
Expert Review of Gastroenterology & Hepatology|March 28, 2023
Comparison of survival rates as predicted by total tumor volume or tumor burden score in patients with hepatocellular carcinoma concurrent with fatty liver disease and hepatitis B virusMin-Jun Li, Si Xie, Yu-Xian Teng, et al.
BMJ Open|September 28, 2023
Hepatectomy combined with apatinib and camrelizumab for CNLC stage IIIb hepatocellular carcinoma: a phase II trial protocolJun Tao Huang, Jian-Hong Zhong, Jie Zhang, et al.
Pageof 21